Presentation TCT 2017

Predicting the Future: Will the Ongoing GALILEO and ENVISAGE AF Trials Change How We Anticoagulate Patients After TAVR?

Presenter: Vinod H. Thourani

October 30, 2017

REGISTER for free or LOG IN to view this content

Predicting the Future: Will the Ongoing GALILEO and ENVISAGE AF Trials Change How We Anticoagulate Patients After TAVR?

Presentation

TCT 2017

Aortic Valve

Up Next

Presentation TCT 2017

Predicting the Future: Will the Ongoing TAVR UNLOAD and Early TAVR Trials Change the Threshold for TAVR in Moderate and Asymptomatic Aortic Stenosis?

Presenter: Allan Schwartz

October 30, 2017

More slides +

Presentation TCT 2017

Predicting The Future: Will the Ongoing COAPT Trial Change How We Treat Patients With Secondary MR in Heart Failure?

Presenter: Gilles Dreyfus

October 30, 2017

Presentation TCT 2017

The BIOMODEX 3D-printed Patient Specific Models for Interventional Cardiology Planification

Presenter: Thomas Marchand

October 30, 2017

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.